CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
D035843:Biomedical Research; D001786:Blood Glucose; D055598:Chemical Phenomena; D002621:Chemistry; D002747:Chlorpropamide; D003920:Diabetes Mellitus; D004358:Drug Therapy; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin; D010600:Pharmacology; D013453:Sulfonylurea Compounds; D014042:Tolazamide; D014044:Tolbutamide; D014116:Toxicology
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014042:Tolazamide; D002747:Chlorpropamide
ANTIDIABETICS; BLOOD SUGAR; CHEMISTRY; CHLORPROPAMIDE; CLINICAL RESEARCH; DIABETES MELLITUS; DRUG THERAPY; INSULIN; PHARMACOLOGY; TOLAZAMIDE; TOLBUTAMIDE; TOXICOLOGIC REPORT